Difference between revisions of "Anatomic Pathology Work Group"
(→Legend) |
|||
(77 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
− | == Status == | + | == Group Status == |
+ | This Work Group has been dissolved (July 25, 2016) and rolled back into the Orders and Observations Work Group (OO) [http://wiki.hl7.org/index.php?title=Orders_%26_Observations_WG]. Anatomic Pathology is not currently meeting separately from OO. | ||
− | + | == Mission == | |
+ | The mission of the Anatomic Pathology WG is to develop and review implementation guides of HL7 standards and to enhance existing HL7 standards to support anatomic pathology use cases. It will work within HL7 as well as with external organizations to facilitate information interoperability in anatomic pathology, such as: | ||
+ | *Tracking of anatomic pathology specimens | ||
+ | *Structuring and coding of anatomic reports | ||
+ | *Integrating and consolidating anatomic pathology data and other data into the medical record (e.g. integrated composite reports) | ||
+ | *Ensuring consistency of anatomic pathology data and corresponding image association (includes both radiology and pathology imaging) | ||
+ | *Reviewing previously defined terms that differ between organizations (e.g. What is a “specimen”) | ||
+ | *Developing/reviewing value sets as needed (e.g. DICOM Specimen Embedding Media) | ||
+ | *Collecting and sharing data from biorepositories/tissue banks | ||
− | + | ---- | |
− | + | ==Charter == | |
− | + | The basic charter of the Anatomic Pathology work group is to initially support the development and implementation of Version 2.x and CDA. Use cases and/or implementation guides brought to the group for review that include Version 3.0 will be addressed on an individual basis. Since the mission of the group is to review existing implementation guides/profiles and recommend changes as needed, as opposed to creating entirely new standard definitions, most work will focus on use case or organization specific needs. | |
− | + | == Current Agenda for May 2016 WG Meeting == | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
==Legend== | ==Legend== | ||
*[[Image:Business_med.gif |business icon]] - business | *[[Image:Business_med.gif |business icon]] - business | ||
Line 28: | Line 30: | ||
{|border="1" cellpadding="2" cellspacing="0" | {|border="1" cellpadding="2" cellspacing="0" | ||
− | |||
| align="center" style="background:#f0f0f0;"|'''Date''' | | align="center" style="background:#f0f0f0;"|'''Date''' | ||
− | | align="center" style="background:#f0f0f0;"|''' | + | | align="center" style="background:#f0f0f0;"|'''Quarter''' |
− | |||
| align="center" style="background:#f0f0f0;"|'''Icon''' | | align="center" style="background:#f0f0f0;"|'''Icon''' | ||
| align="center" style="background:#f0f0f0;"|'''Event''' | | align="center" style="background:#f0f0f0;"|'''Event''' | ||
Line 39: | Line 39: | ||
|- | |- | ||
| rowspan="4" | Monday | | rowspan="4" | Monday | ||
− | |||
− | |||
|Q1 | |Q1 | ||
| | | | ||
Line 48: | Line 46: | ||
| | | | ||
|- | |- | ||
− | |||
− | |||
|Q2 | |Q2 | ||
| | | | ||
Line 57: | Line 53: | ||
| | | | ||
|- | |- | ||
− | |||
− | |||
|Q3 | |Q3 | ||
| | | | ||
Line 66: | Line 60: | ||
| | | | ||
|- | |- | ||
− | |||
− | |||
|Q4 | |Q4 | ||
| | | | ||
Line 75: | Line 67: | ||
| | | | ||
|-border="4" cellpadding="8" style="background:#f0f0f0;" | |-border="4" cellpadding="8" style="background:#f0f0f0;" | ||
− | |. | + | |. |||||||||||||||| |
|- | |- | ||
− | | rowspan="4" | Tuesday | + | | rowspan="4" | Tuesday |
− | |||
− | |||
|Q1 | |Q1 | ||
|[[Image:Business_med.gif |business icon]] | |[[Image:Business_med.gif |business icon]] | ||
Line 87: | Line 77: | ||
| | | | ||
|- | |- | ||
− | |||
− | |||
|Q2 | |Q2 | ||
|[[Image:Technical_med.gif |technical icon]] | |[[Image:Technical_med.gif |technical icon]] | ||
− | | | + | |IHE and DICOM updates and related projects (specimen, workflow) |
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
− | |||
− | |||
|Q3 | |Q3 | ||
− | |[[Image: | + | |[[Image:Technical_med.gif |technical icon]] |
− | | | + | |Joint with CG (AP hosting), Joint projects around specimen mode, AP/molecular workflow, and IOM efforts |
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
− | |||
− | |||
|Q4 | |Q4 | ||
− | |[[Image: | + | |[[Image:Business_med.gif |business icon]] |
− | | | + | |Wrap-up, next steps |
− | |||
| | | | ||
| | | | ||
Line 118: | Line 101: | ||
|- | |- | ||
| rowspan="4" | Wednesday | | rowspan="4" | Wednesday | ||
+ | |Q1 | ||
| | | | ||
− | | | + | |No meeting |
− | |||
− | |||
− | |||
− | |||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
− | |||
− | |||
|Q2 | |Q2 | ||
|[[Image:Technical_med.gif |technical icon]] | |[[Image:Technical_med.gif |technical icon]] | ||
− | | | + | |Joint with O&O |
− | |||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
+ | |Q3 | ||
| | | | ||
− | | | + | |No meeting |
− | |||
− | |||
− | |||
− | |||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
+ | |Q4 | ||
| | | | ||
− | | | + | |No meeting |
− | |||
− | |||
− | |||
− | |||
| | | | ||
| | | | ||
Line 161: | Line 132: | ||
|- | |- | ||
| rowspan="4" | Thursday | | rowspan="4" | Thursday | ||
− | |||
− | |||
|Q1 | |Q1 | ||
− | | | + | | |
− | | | + | | No meeting |
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
− | |||
− | |||
|Q2 | |Q2 | ||
| | | | ||
− | | | + | | No meeting |
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
− | |||
− | |||
|Q3 | |Q3 | ||
| | | | ||
Line 188: | Line 153: | ||
| | | | ||
|- | |- | ||
− | |||
− | |||
|Q4 | |Q4 | ||
| | | | ||
Line 201: | Line 164: | ||
|- | |- | ||
| rowspan="4" | Friday | | rowspan="4" | Friday | ||
− | |||
− | |||
|Q1 | |Q1 | ||
| | | | ||
Line 211: | Line 172: | ||
| | | | ||
|- | |- | ||
− | |||
− | |||
|Q2 | |Q2 | ||
| | | | ||
Line 221: | Line 180: | ||
| | | | ||
|- | |- | ||
− | |||
− | |||
|Q3 | |Q3 | ||
| | | | ||
Line 230: | Line 187: | ||
| | | | ||
|- | |- | ||
− | |||
− | |||
|Q4 | |Q4 | ||
| | | | ||
Line 258: | Line 213: | ||
*[[AP_WGM_Agenda_September_2012 | AP WGM Agenda September 2012]] | *[[AP_WGM_Agenda_September_2012 | AP WGM Agenda September 2012]] | ||
+ | === Agenda for Scottsdale, January 2013 === | ||
+ | |||
+ | *[[Agenda_for_Scottsdale,_January_2013| AP WGM Agenda January 2013]] | ||
+ | |||
+ | === Agenda for Atlanta, May 2013 === | ||
+ | |||
+ | *[[Agenda_for_Atlanta,_May_2013| AP WGM Agenda May 2013]] | ||
---- | ---- | ||
=='''Temporary Contents'''== | =='''Temporary Contents'''== | ||
− | === Files for Review === | + | |
+ | |||
+ | |||
+ | === Files/Links for Review === | ||
+ | |||
+ | Draft M&C v3 for review [http://wiki.hl7.org/images/f/f9/AP_WG_M%26C_v3.1.docx] | ||
+ | |||
+ | Draft minutes from latest conference call [http://wiki.hl7.org/images/7/7b/AP_WG_CC_7-23-2014-draft.docx] | ||
+ | |||
+ | Sample APSR from HL7 Germany [http://wiki.hl7.org/images/a/a9/Sample_APSR.zip] | ||
+ | |||
+ | Companion text for the above APSR [http://wiki.hl7.org/images/a/a0/APSR_UrinaryBladder_Prostate_plaintext.doc] | ||
+ | |||
+ | May 2104 WGM Minutes for Review [http://wiki.hl7.org/index.php?title=File:2014-05_WG_Minutes_Draft.docx] | ||
+ | |||
+ | JD's DICOM talk [http://wiki.hl7.org/images/9/91/DICOM_talk.pptx] | ||
+ | |||
+ | DICOM AP Workflows [http://wiki.hl7.org/images/c/cb/DICOM_Workflow_10-21-13mw.pptx] | ||
+ | |||
+ | CAP Cancer Biomarker Project [http://wiki.hl7.org/index.php?title=File:HL7_-_CAP_Cancer_Biomarker_Reporting_Committee.pptx] | ||
+ | |||
+ | Draft SWOT [http://wiki.hl7.org/index.php?title=File:HL7_AP_WG_SWOT_Sept_2013-draft.docx] | ||
+ | |||
+ | Draft WGM Minutes for review (Sept 2013 WGM) [http://wiki.hl7.org/index.php?title=File:2013-09_WG_Minutes_Draft.docx] | ||
+ | |||
+ | Draft DMP for review [http://wiki.hl7.org/images/7/73/Anatomic_Pathology_HL7_WG_DMP_v2.0_fnl.docx] | ||
+ | |||
+ | Trello Concept | ||
+ | |||
+ | Trello Board [https://trello.com/b/kZmtQ1WV/hl7-anatomic-pathology-working-group] | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | '''HL7 Germany Work on Lab Specimen Reports''' | ||
+ | |||
+ | Original Work (in German) [http://wiki.hl7.org/index.php?title=File:Addendum-Lab-v100.pdf] | ||
+ | |||
+ | English translation [http://wiki.hl7.org/index.php?title=File:Addendum-Lab-v100.de.en.docx] | ||
+ | |||
+ | |||
+ | Latest Version of Ballot | ||
+ | |||
+ | [http://wiki.hl7.org/index.php?title=File:Unique_ID_Informative_next_version-_.docx] | ||
+ | |||
+ | Latest Ballot Comments | ||
+ | |||
+ | [http://wiki.hl7.org/index.php?title=File:Ballotcomments_V3_DAM_ANATPATHSPECID_R1_I2_2013JAN-master.xls] | ||
+ | |||
Update 20120628: Updated Spec ID doc | Update 20120628: Updated Spec ID doc | ||
Latest revision as of 21:02, 19 January 2017
Contents
Group Status
This Work Group has been dissolved (July 25, 2016) and rolled back into the Orders and Observations Work Group (OO) [1]. Anatomic Pathology is not currently meeting separately from OO.
Mission
The mission of the Anatomic Pathology WG is to develop and review implementation guides of HL7 standards and to enhance existing HL7 standards to support anatomic pathology use cases. It will work within HL7 as well as with external organizations to facilitate information interoperability in anatomic pathology, such as:
- Tracking of anatomic pathology specimens
- Structuring and coding of anatomic reports
- Integrating and consolidating anatomic pathology data and other data into the medical record (e.g. integrated composite reports)
- Ensuring consistency of anatomic pathology data and corresponding image association (includes both radiology and pathology imaging)
- Reviewing previously defined terms that differ between organizations (e.g. What is a “specimen”)
- Developing/reviewing value sets as needed (e.g. DICOM Specimen Embedding Media)
- Collecting and sharing data from biorepositories/tissue banks
Charter
The basic charter of the Anatomic Pathology work group is to initially support the development and implementation of Version 2.x and CDA. Use cases and/or implementation guides brought to the group for review that include Version 3.0 will be addressed on an individual basis. Since the mission of the group is to review existing implementation guides/profiles and recommend changes as needed, as opposed to creating entirely new standard definitions, most work will focus on use case or organization specific needs.
Current Agenda for May 2016 WG Meeting
Legend
- - business
- - ballot reconciliation
- - technical
- / = joint session
- + = session with representatives of
Past Agendas
Agenda for San Diego, 2011
Agenda for San Antonio, 2012
Agenda for Vancouver, BC 2012
Agenda for Baltimore, 2012
Agenda for Scottsdale, January 2013
Agenda for Atlanta, May 2013
Temporary Contents
Files/Links for Review
Draft M&C v3 for review [2]
Draft minutes from latest conference call [3]
Sample APSR from HL7 Germany [4]
Companion text for the above APSR [5]
May 2104 WGM Minutes for Review [6]
JD's DICOM talk [7]
DICOM AP Workflows [8]
CAP Cancer Biomarker Project [9]
Draft SWOT [10]
Draft WGM Minutes for review (Sept 2013 WGM) [11]
Draft DMP for review [12]
Trello Concept
Trello Board [13]
HL7 Germany Work on Lab Specimen Reports
Original Work (in German) [14]
English translation [15]
Latest Version of Ballot
Latest Ballot Comments
Update 20120628: Updated Spec ID doc